BrickBio, Inc.
PrivateLast Round
VC Round
Mar 18, 2024
Est. Valuation
$20M
Total Funding Raised
$5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BrickBio, Inc. is a biotechnology company that develops a bioconjugation platform for the site-specific modification of proteins to create novel biologics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrickBio, Inc. Comparables
Compare BrickBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRO Biosciences | 85% | |
| VALANX Biotech | 82% | |
| Lonza Group | 75% |
BrickBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 18, 2024 | ||||
| Series A | Nov 22, 2019 |
Key People
Founding team and executive leadership
BrickBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Samsung Venture Investment | VC Round |
| TigerGene | Series A |
| Samsung Life Science Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 903% MoM, from 145 to 1.5K.
- Jul 26, 2026
Monthly visitors grew 84% MoM, from 79 to 145.
BrickBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BrickBio, Inc.'s valuation, stock price, and market status.
Is BrickBio, Inc. a public or private company?
BrickBio, Inc. is a private company.
What is the current stock price of BrickBio, Inc.?
BrickBio, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BrickBio, Inc. worth (valuation)?
BrickBio, Inc.'s valuation is estimated at $20.0M based on funding round data.
Can I buy BrickBio, Inc. stock?
BrickBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BrickBio, Inc.'s last funding round?
BrickBio, Inc.'s most recent funding round was VC Round on November 22, 2019.
Who are the main investors in BrickBio, Inc.?
Key investors in BrickBio, Inc. include Samsung Venture Investment, TigerGene, Samsung Life Science Fund.
Will BrickBio, Inc. IPO soon?
No public IPO plans have been announced for BrickBio, Inc..
How can I track BrickBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BrickBio, Inc.'s secondary market activity and sign up for updates.